This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Corneal Industrie. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Denis Gantin
Introduction
Denis Gantin is a notable inventor based in Bonneville, France. He has made significant contributions to the field of ophthalmology through his innovative designs and patents. His work focuses on improving intraocular implants, which are crucial for vision correction.
Latest Patents
Denis Gantin holds a patent for an intraocular implant. This invention features an optical portion with an anterior and posterior optical surface, along with at least one haptic element. Each haptic element includes a connection zone at the periphery of the optical portion. The design incorporates a cylindrical side face connected to the posterior optical surface, enhancing the functionality and effectiveness of the implant.
Career Highlights
Gantin's career is marked by his dedication to advancing medical technology. His work at Corneal Industrie has allowed him to focus on developing innovative solutions for eye care. The intraocular implant he designed represents a significant advancement in the field, showcasing his expertise and commitment to improving patient outcomes.
Collaborations
Denis Gantin collaborates with Gilles Bos, contributing to the development of cutting-edge technologies in ophthalmology. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Denis Gantin's contributions to the field of intraocular implants highlight his role as a pioneering inventor. His patent reflects a commitment to enhancing vision correction technologies, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile